SPORANOX (Janssen Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the SPORANOX drug offered from Janssen Pharmaceuticals, Inc.. This Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Janssen Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | ITRACONAZOLE |
SUBSTANCE NAME: | ITRACONAZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Azole Antifungal [EPC],Azoles [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1992-09-11 |
END MARKETING DATE: | 0000-00-00 |
SPORANOX HUMAN PRESCRIPTION DRUG Details:
Item Description | SPORANOX from Janssen Pharmaceuticals, Inc. |
LABELER NAME: | Janssen Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 1992-09-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 50458-290_b61076ee-a00a-45ba-b8c8-9278dca8c105 |
PRODUCT NDC: | 50458-290 |
APPLICATION NUMBER: | NDA020083 |
Other ITRACONAZOLE Pharmaceutical Manufacturers / Labelers: